LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 56.45 | 27.76 | 2185 | 5745 | 0.3803 | 0.7638 | MN20160318_Q01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 58.15 | 27.76 | 101 | 5906 | 0.0171 | 0.1818 | MN20160318_Q01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 58.15 | 27.76 | 1899 | 5906 | 0.3215 | 0.7270 | MN20160318_Q01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 58.15 | 27.76 | 360 | 5906 | 0.0609 | 0.3929 | MN20160318_Q01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 58.15 | 27.76 | 2225 | 5906 | 0.3767 | 0.7628 | MN20160318_Q01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 59.85 | 27.76 | 125 | 6062 | 0.0206 | 0.2137 | MN20160318_Q01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 59.85 | 27.76 | 1972 | 6062 | 0.3253 | 0.7309 | MN20160318_Q01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 59.85 | 27.76 | 367 | 6062 | 0.0605 | 0.3941 | MN20160318_Q01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 59.85 | 27.76 | 2319 | 6062 | 0.3825 | 0.7674 | MN20160318_Q01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 61.56 | 27.76 | 135 | 6217 | 0.0217 | 0.2246 | MN20160318_Q01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 61.56 | 27.76 | 2037 | 6217 | 0.3276 | 0.7336 | MN20160318_Q01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 61.56 | 27.76 | 417 | 6217 | 0.0671 | 0.4149 | MN20160318_Q01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 61.56 | 27.76 | 2424 | 6217 | 0.3899 | 0.7727 | MN20160318_Q01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 63.26 | 27.76 | 140 | 6465 | 0.0217 | 0.2285 | MN20160318_Q01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 63.26 | 27.76 | 2148 | 6465 | 0.3322 | 0.7385 | MN20160318_Q01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 63.26 | 27.76 | 445 | 6465 | 0.0688 | 0.4231 | MN20160318_Q01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 63.26 | 27.76 | 2524 | 6465 | 0.3904 | 0.7745 | MN20160318_Q01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 64.97 | 27.76 | 151 | 6656 | 0.0227 | 0.2389 | MN20160318_Q01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 64.97 | 27.76 | 2218 | 6656 | 0.3332 | 0.7404 | MN20160318_Q01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 64.97 | 27.76 | 453 | 6656 | 0.0681 | 0.4236 | MN20160318_Q01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 64.97 | 27.76 | 2606 | 6656 | 0.3915 | 0.7763 | MN20160318_Q01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 66.67 | 27.76 | 174 | 6695 | 0.0260 | 0.2610 | MN20160318_Q01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 66.67 | 27.76 | 2292 | 6695 | 0.3423 | 0.7466 | MN20160318_Q01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 66.67 | 27.76 | 406 | 6695 | 0.0606 | 0.4035 | MN20160318_Q01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 66.67 | 27.76 | 2681 | 6695 | 0.4004 | 0.7816 | MN20160318_Q01 | L17 |